• Company
• New AML drug Vyxeos can be prescribed at Big 5 hospitals
• by Eo, Yun-Ho Nov 1, 2024 05:51am

• Policy
• Hyundai withdraws application for Mifegymiso approval again
• by Lee, Hye-Kyung Nov 1, 2024 05:50am

• Company
• Novartis’s operating income grew 123% in Q3 with Entresto
• by Son, Hyung Min Nov 1, 2024 05:50am

• Company
• Atopic dermatitis drug Ebglyss to enter Korea next year
• by Whang, byung-woo Oct 31, 2024 05:55am

• Company
• Oral ALS drug 'Radicava' likely to land in KOR
• by Eo, Yun-Ho Oct 31, 2024 05:55am

• Company
• Pfizer's Q3 sales 31%↑amid increased demand for COVID-19
• by Son, Hyung Min Oct 31, 2024 05:55am

• Company
• NIP inclusion of HPV vaccines on the horizon
• by Whang, byung-woo Oct 31, 2024 05:55am

• Policy
• Seretide withdraws from Korea due to poor performance
• by Lee, Tak-Sun Oct 31, 2024 05:55am

• InterView
• "Recruiting a company to co-develop pitavastatin+ezetimibe"
• by Kim, Jin-Gu Oct 30, 2024 05:54am

• Company
• Difficulty expanding indications for antibody-drug conjugate
• by Moon, sung-ho Oct 30, 2024 05:54am